PD-L1 Testing Should Be Standard for Every Suspected Lung Cancer

Dr. Mark Kris of Memorial Sloan Kettering Cancer Center argues that PD-L1 testing should be a standard evaluation in patients with lung cancer. Dr. Kris also makes the point that it is critical for oncologists to get the word out among their colleagues regarding the importance of this testing and notes the crucial issue of ensuring that an adequate tumoer sample is submitted for the immunohistochemistry-based test.